Apogee Therapeutics, Inc.

Q2 2025 13F Holders

Symbol
APGE
CUSIP
03770N101
Type
Equity
Class
COM
Num filings
201
Total reported value, excl. options
$2.52 B
Manager Report Date Value ($000) Shares Option Type